市场调查报告书
商品编码
1587688
至 2030 年槐醣脂市场预测:按类型、配方类型、功能、应用和地区进行的全球分析Sophorolipids Market Forecasts to 2030 - Global Analysis By Type (Acidic Sophorolipids and Lactonic Sophorolipids), Formulation Type (Liquid Sophorolipids and Powdered Sophorolipids), Functionality, Application and by Geography |
根据 Stratistics MRC 的数据,2024 年全球槐醣脂市场规模为 5.3396 亿美元,预计 2030 年将达到 8.0493 亿美元,预测期内复合年增长率为 7.08%。
槐醣脂是一种生物界面活性剂,由某些酵母菌(如假丝酵母)透过发酵植物油和糖等可再生资源而产生。这种无毒且生物分解性的材料用于药品、清洁剂、化妆品和农业等各个领域,并因其环保特性而受到关注。槐醣脂以其降低表面张力的能力而闻名,使其可用作配方中的稳定剂、清洗和乳化剂。
根据《生物技术进展》杂誌上发表的一项研究,槐醣脂因其低毒性、高生物分解性和有效的界面活性剂特性而成为最有前途的生物表面活性剂之一。研究还强调,槐醣脂可以将表面张力降低至 33 mN/m,使其在清洁剂和个人保健产品等各种应用中非常有效。
消费者对环保产品的兴趣日益浓厚
消费者对环境问题以及合成化学物质对生态系统和人类健康造成的危害的认识不断提高,正在推动对环保产品的需求。槐醣脂无毒、生物分解性,并且源自可再生资源,这使其成为传统界面活性剂的替代品。此外,向永续性的转变在个人护理和家庭清洗行业中尤为明显,这些行业正在积极努力改进其产品,以满足消费者对天然成分的偏好。
製造成本高
槐醣脂的生产成本比传统的合成界面活性剂更高,因为它们通常需要复杂的发酵程序和专门的原料。这种价差可能会限制其吸引力,特别是在消费者和企业关注物有所值的市场中。此外,下游加工和精製的高成本进一步加剧了这个问题,使得槐醣脂很难与知名的化学界面活性剂进行价格竞争。
製药和医疗产业的成长
槐醣脂在药物传输系统和医疗应用中的广泛使用预计将推动医疗药品领域的显着成长。由于其低毒性、生物相容性和抗菌特性,它可用于多种药物配方,包括医疗设备和创伤护理产品的涂层。此外,该行业的发展为製造商提供了创造新产品和应用的丰富机会。
与人工界面活性剂的激烈竞争
槐醣脂市场的最大威胁是成熟的合成界面活性剂,因为它们具有经过验证的性能和较低的製造成本。这些传统的界面活性剂在许多领域都很成熟,包括工业应用、清洁剂和个人护理。此外,说服生产商和消费者从众所周知的合成替代品转向槐醣脂等生物基替代品是很困难的,特别是当成本和功能是决策的关键考虑因素时,如果是这样,这是一项艰鉅的任务。正因为如此,市场不愿意接受更现代、更环保的解决方案。
槐醣脂市场受到 COVID-19 大流行的严重影响,其主要原因是生产延误、经济不确定性和全球供应链中断。北美、欧洲和亚洲的停产和公司倒闭阻碍了生产能力,减少了这些生物基界面活性剂的供应。儘管疫情的爆发将永续性和卫生作为重点,但各行业的审慎支出抑制了整体市场成长。然而,随着行业逐步恢復运营,供应紧张开始缓解,特别是医药、个人护理等行业,对槐醣脂的新需求出现。
预计酸性槐醣脂部分在预测期内将是最大的
由于其广泛的应用和有利的特性,酸性槐醣脂部分在槐醣脂市场中占据主导地位。一些酵母菌种,特别是 Starmerella bidicola 的发酵,会产生酸性槐醣脂,众所周知,槐醣脂是双亲性的,因此是有效的表面活性剂。酸性槐醣脂具有高度水溶性并具有强大的发泡特性,使其适用于生物修復、乳製品和化妆品等多种应用。此外,它们比合成界面活性剂更俱生物分解性且毒性更小,这使得它们越来越有吸引力,特别是随着消费者对更绿色和更永续产品的偏好而改变。
预计皮肤调理剂细分市场在预测期内复合年增长率最高
在预测期内,槐醣脂市场的皮肤调理剂部分预计将以最高复合年增长率成长。个人保健产品(尤其是护肤配方)对安全高效成分的需求不断增长,是这项扩张的关键驱动力。槐醣脂以温和且高度保湿而闻名,是优秀的皮肤调理剂,可增强产品的性能而不刺激皮肤。此外,它能够增加水合作用并提供光滑的质地,使其在乳液、乳霜和其他化妆品应用中非常受欢迎。
槐醣脂市场由欧洲主导。严格的环境法以及消费者和製造商对永续实践的坚定承诺是这一优势的关键因素。欧洲在槐醣脂市场处于领先地位,因为它专注于减少对石化产品的依赖并提高消费者对环保替代品的认识。此外,由于产品开发的进步和个人护理、农业和製药等许多行业的应用不断扩大,永续性仍然是重中之重,预计欧洲市场将进一步成长。
由于快速的工业化和对永续解决方案的兴趣日益浓厚,槐醣脂市场预计将以亚太地区最高的复合年增长率增长。生物基界面活性剂越来越多地用于化妆品、药品和农业,其中中国和印度等国家引领了这种扩张。该地区对绿色技术和环保意识的倾向进一步推动了对槐醣脂的需求,因为消费者和企业都在寻求传统化学表面活性剂的环保替代品。此外,支持生物基产品的政府计画也有望促进市场成长,亚太地区将成为未来几年槐醣脂市场的主要参与企业。
According to Stratistics MRC, the Global Sophorolipids Market is accounted for $533.96 million in 2024 and is expected to reach $804.93 million by 2030 growing at a CAGR of 7.08% during the forecast period. Sophorolipids are a type of biosurfactant produced by certain yeast species, such as Candida bombicola, through the fermentation of renewable resources like vegetable oils and sugars. These non-toxic, biodegradable substances are utilized in a variety of sectors, such as pharmaceuticals, detergents, cosmetics, and agriculture, and have drawn notice for their eco-friendly qualities. Because of their well-known capacity to lower surface tension, sophorolipids are useful stabilizers, detergents, and emulsifiers in formulations.
According to a study published in the journal Biotechnology Advances, sophorolipids are among the most promising biosurfactants due to their low toxicity, high biodegradability, and effective surface-active properties. The study also highlights that sophorolipids can reduce surface tension to as low as 33 mN/m, making them highly effective in various applications such as detergents and personal care products.
Growing consumer interest in eco-friendly products
The demand for eco-friendly products is being driven by consumers growing awareness of environmental issues and the harm that synthetic chemicals cause to ecosystems and human health. Sophorolipids are appealing substitutes for conventional surfactants because they are non-toxic, biodegradable, and derived from renewable resources. Additionally, in the personal care and household cleaning industries, where companies are actively working to reformulate products to satisfy consumer preferences for natural ingredients, this shift towards sustainability is especially noticeable.
High costs of production
Sophorolipids are more expensive to produce than traditional synthetic surfactants because they frequently require intricate fermentation procedures and specialized raw materials. Their appeal may be limited by this price difference, particularly in markets where consumers and businesses place a high value on cost-effectiveness. Furthermore, this problem is made even worse by the high expenses of downstream processing and purification, which make it challenging for sophorolipids to compete on price with well-known chemical surfactants.
Growth in the pharmaceutical and healthcare industries
The growing use of sophorolipids in drug delivery systems and medical applications is anticipated to drive significant growth in the healthcare and pharmaceuticals segment. Because of their low toxicity, biocompatibility, and antimicrobial qualities, they can be used in a variety of pharmaceutical formulations, such as medical device coatings and wound care products. Moreover, the growth of this industry presents manufacturers with rich chances to create new products and applications.
Strong competition from artificial surfactants
Due to their well-established performance and lower production costs, established synthetic surfactants pose the biggest threat to the sophorolipids market. These traditional surfactants are well-established in a number of sectors, such as industrial applications, detergents, and personal care. Additionally, convincing producers and consumers to move from well-known synthetic alternatives to bio-based substitutes like sophorolipids is a difficult task, particularly when cost and functionality are important considerations when making decisions. Because of this, the market is hesitant to embrace more modern, environmentally friendly solutions.
The market for sophorolipids was greatly impacted by the COVID-19 pandemic, mostly due to delays in manufacturing, economic uncertainty, and disruptions in global supply chains. Production capacity was hampered by lockdowns and company closures in North America, Europe, and Asia, which reduced the supply of these bio-based surfactants. Overall market growth was constrained by cautious spending across industries, despite the pandemic's increased emphasis on sustainability and hygiene. However, a renewed need for sophorolipids arose as industries gradually resumed operations and supply constraints started to lessen, especially in industries like pharmaceuticals and personal care.
The Acidic Sophorolipids segment is expected to be the largest during the forecast period
Due to its many uses and advantageous characteristics, the acidic sophorolipid segment dominates the sophorolipids market. The fermentation of several yeast species, most notably Starmerella bombicola, yields acidic sophorolipids, which are known for being amphiphilic and thus making them efficient surfactants. Because of their greater water solubility and potent foaming properties, acidic sophorolipids are appropriate for a variety of applications, such as bioremediation, dairy, and cosmetics. Moreover, their increased biodegradability and decreased toxicity in comparison to synthetic surfactants add to their allure, especially as consumer preferences for environmentally friendly and sustainable products change.
The Skin Conditioning Agents segment is expected to have the highest CAGR during the forecast period
Over the course of the forecast period, the sophorolipids market's skin conditioning agents segment is anticipated to grow at the highest CAGR. The rising demand for safe and efficient ingredients in personal care products, especially skincare formulas, is the main driver of this expansion. Well-known for their skin-friendly and moisturizing qualities, sophorolipids are great skin conditioning agents that improve product performance without being harsh on the skin. Additionally, they are highly sought after in lotions, creams, and other cosmetic applications because of their capacity to enhance hydration and offer a smooth texture.
The market for sophorolipids is dominated by the European region. Strict environmental laws and a strong emphasis on sustainable practices by both consumers and manufacturers are the main drivers of this dominance. Europe is positioned as a leader in the sophorolipids market due to the region's dedication to lowering dependency on petrochemical-based products and growing consumer awareness of environmentally friendly alternatives. Furthermore, the European market is anticipated to grow even more as sustainability remains a top priority, propelled by advancements in product development and expanding applications in a number of industries, such as personal care, agriculture, and pharmaceuticals.
The market for sophorolipids is expected to grow at the highest CAGR in the Asia-Pacific region due to rapid industrialization and a growing focus on sustainable solutions. As bio-based surfactants are increasingly used in cosmetics, pharmaceuticals, and agriculture, nations like China and India are leading the way in this expansion. The demand for sophorolipids is further increased by the region's dedication to green technologies and environmental awareness, as both consumers and businesses look for environmentally friendly substitutes for conventional chemical surfactants. Moreover, government programs supporting bio-based products are also anticipated to support market growth, positioning Asia-Pacific as a major player in the sophorolipids market going forward.
Key players in the market
Some of the key players in Sophorolipids market include BASF SE, Evonik Industries AG, Unilever, Holiferm Limited, Allied Carbon Solutions Co., Ltd., Givaudan SA, Ferro Corporation, Biobar Pty Ltd., Tokyo Chemical Industry, Syngenta AG, Koninklijke DSM N.V., Saraya Co. Ltd, Dow Inc., Mg Intobio Co Ltd, Soliance, Henkel AG & Co. KGaA, Sabic and Kaneka Corporation.
In July 2024, BASF and ENGIE signed a 7-year Biomethane Purchase Agreement (BPA). Under the BPA, ENGIE will supply BASF with 2.7 to 3.0 terawatt hours of biomethane throughout the term of the agreement. BASF uses certified biomethane at its Ludwigshafen/Germany and Antwerp/Belgium sites as a sustainable alternative to fossil raw materials in its manufacturing process.
In May 2023, Dow and New Energy Blueopens announced a long-term supply agreement in North America in which New Energy Blue will create bio-based ethylene from renewable agricultural residues. Dow expects to purchase this bio-based ethylene, reducing carbon emissions from plastic production, and using it in recyclable applications across transportation, footwear, and packaging.
In January 2023, Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd., announced collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.